News on TrialBuilder LLC from BioPortfolio.com http://www.BioPortfolio.com Consolidated TrialBuilder LLC news from BioPortfolio.com Wed, 10 Feb 2010 15:13:19 GMT en Dementia: A Focused Reviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039865&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039865&THISHREF=http://c.moreover.com/click/here.pl%3fz2538440215%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039865&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039865&THISHREF=http://c.moreover.com/click/here.pl%3fz2538440215%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPsychiatric Times: Dementia: A Focused Reviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039862&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039862&THISHREF=http://c.moreover.com/click/here.pl%3fz2538439823%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039862&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039862&THISHREF=http://c.moreover.com/click/here.pl%3fz2538439823%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPsychiatric Times: RSB Spine, LLC, Announces FDA Clearance for Its InterPlate C-PS and L-PS Interbody Spacershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041545&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041545&THISHREF=http://c.moreover.com/click/here.pl%3fz2539163297%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041545&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041545&THISHREF=http://c.moreover.com/click/here.pl%3fz2539163297%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Ricerca Announces Intent to Acquire MDS Pharma Services Businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042767&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042767&THISHREF=http://c.moreover.com/click/here.pl%3fz2539521169%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042767&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042767&THISHREF=http://c.moreover.com/click/here.pl%3fz2539521169%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Avrio Receives Drug Manufacturing License and Medical Device Manufacturing License from the California Food and Drug Branchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041695&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041695&THISHREF=http://c.moreover.com/click/here.pl%3fz2539207214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041695&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041695&THISHREF=http://c.moreover.com/click/here.pl%3fz2539207214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Week of February 8, 2010. Click the page to download the issue!http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039751&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039751&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357794%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039751&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039751&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357794%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDenver's Nursing Star: Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038924&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038924&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837928%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038924&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038924&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837928%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038325&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038325&THISHREF=http://c.moreover.com/click/here.pl%3fz2537567392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038325&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038325&THISHREF=http://c.moreover.com/click/here.pl%3fz2537567392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via Yahoo!: Akrimax Pharmaceuticals, LLC-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037916&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037916&THISHREF=http://c.moreover.com/click/here.pl%3fz2537371405%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037916&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037916&THISHREF=http://c.moreover.com/click/here.pl%3fz2537371405%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Aleppo Pharmaceutical Industries, L.L.C.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037827&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037827&THISHREF=http://c.moreover.com/click/here.pl%3fz2537321987%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037827&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037827&THISHREF=http://c.moreover.com/click/here.pl%3fz2537321987%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Amneal Pharmaceuticals, LLC-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037411&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037411&THISHREF=http://c.moreover.com/click/here.pl%3fz2537065057%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037411&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037411&THISHREF=http://c.moreover.com/click/here.pl%3fz2537065057%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: ApopLogic Pharmaceuticals, LLC-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036851&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036851&THISHREF=http://c.moreover.com/click/here.pl%3fz2536790917%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036851&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036851&THISHREF=http://c.moreover.com/click/here.pl%3fz2536790917%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Bioniche Pharma USA, LLC-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034722&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034722&THISHREF=http://c.moreover.com/click/here.pl%3fz2535944617%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034722&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034722&THISHREF=http://c.moreover.com/click/here.pl%3fz2535944617%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Cenomed BioSciences, LLC-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033879&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033879&THISHREF=http://c.moreover.com/click/here.pl%3fz2535468709%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033879&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033879&THISHREF=http://c.moreover.com/click/here.pl%3fz2535468709%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Endo Pharmaceuticals Completes Secondary Offerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036039&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036039&THISHREF=http://c.moreover.com/click/here.pl%3fz2536476930%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036039&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TrialBuilder%20LLC&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036039&THISHREF=http://c.moreover.com/click/here.pl%3fz2536476930%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCitybizlist: